Biotech

All Articles

James Wilson leaving behind Penn to release pair of brand new biotechs

.After greater than 30 years, genetics therapy pioneer James Wilson M.D., Ph.D., is actually leaving...

3 biotechs attempt to beat the summer months heat energy by dropping team

.As biotechs attempt to switch a fresh webpage in August, a minimum of 3 firms have shed team in att...

venBio raises $528M for fifth life sciences VC fund

.Pro venture capital agency venBio has actually lifted another half a billion dollars to buy biotech...

Otsuka pays for $800M for Jnana and also its clinical-stage PKU drug

.Otsuka Drug has actually picked up Boston-based Jnana Therapies for $800 million so the Japanese bi...

FibroGen gives up 75% of US personnel as resource flunks 2 even more trials

.FibroGen is drastically reorganizing its own company, laying off 75% of its U.S. personnel and stop...

Tracon unwind full weeks after injectable PD-L1 prevention fall short

.Tracon Pharmaceuticals has decided to unwind procedures full weeks after an injectable invulnerable...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is betting $400 million in biobucks that a bispecific antibody-drug conjugate (A...

Takeda takes $140M reduction on failed epilepsy medication, boasts FDA manage

.Our team actually understand that Takeda is actually wanting to discover a road to the FDA for epil...

VBI Injections declare bankruptcy, looks for resource purchase

.Immunology biotech VBI Injections is turning dangerously close to the point of no return, along wit...

Celldex anti-cKIT antibody decrease colonies in another stage 2 study

.It's not easy to muscle mass in on an area as competitive as immunology, yet Celldex Rehabs thinks ...